Stability-indicating liquid chromatographic method for quantification of new anti-epileptic drug lacosamide in bulk and pharmaceutical formulation

• Main Authors: Chhalotiya Usmangani K., Bhatt Kashyap K., Shah Dimal A., Baldania Sunil L., Patel Jigar R.
• Format: Article
• Language: English
• Published: Association of the Chemical Engineers of Serbia 2012-01-01
• Series: Chemical Industry and Chemical Engineering Quarterly
• Subjects: Lacosamide; Forced degradation; Reversed phase liquid chromatography; Validation
• Online Access: http://www.doiserbia.nb.rs/img/doi/1451-9372/2012/1451-93721100044C.pdf

An isocratic stability indicating reversed-phase liquid chromatographic determination was developed for the quantitative determination of lacosamide in the pharmaceutical dosage form. A Hypersil C-18, 4.5μm column with mobile phase containing acetonitrile-water (20:80, v/v) was used. The flow rate was 1.0 mL min-1 and effluents were monitored at 258 nm. The retention time of lacosamide was 8.9 min. The method was found to be linear in the concentration range of 5-100 μg/ml and the recovery was found to be in the range of 99.15 - 100.09 %. The limit of detection and limit of quantification were found to be 2 μg/ml and 5 μg/ml, respectively. Lacosamide stock solutions were subjected to acid and alkali hydrolysis, chemical oxidation and dry heat degradation. The drug was found to be stable to the dry heat and acidic condition attempted. The proposed method was validated and successfully applied to the estimation of lacosamide in tablet dosage forms.